Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients
  2. Glynn, S. A.; Boersma, B. J.; Dorsey, T. H.; Yi, M.; Yfantis, H. G.; Ridnour, L. A.; Martin, D. N.; Switzer, C. H.; Hudson, R. S.; Wink, D. A.; Lee, D. H.; Stephens, R. M.; Ambs, S.
  3. Journal of Clinical Investigation. 2010, Nov; 120(11): 3843-3854.
  1. 2.   Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation
  2. Huang, J.; Chen, K. Q.; Huang, J. Q.; Gong, W. H.; Dunlop, N. M.; Howard, O.; Bian, X. W.; Gao, Y. Q.; Wang, J. M.
  3. Carcinogenesis. 2009 30(2): 348-355.
  1. 3.   C/EBP delta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution
  2. Thangaraju, M.; Rudelius, M.; Bierie, B.; Raffeld, M.; Sharan, S.; Hennighausen, L.; Huang, A. M.; Sterneck, E.
  3. Development. 2005, NOV; 132(21): 4675-4685.
  1. 4.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 5.   5-Lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking
  2. Catalano, A.; Caprari, P.; Soddu, S.; Procopio, A.; Romano, M.
  3. Faseb Journal. 2004, SEP; 18(12): Published online only.
  1. 6.   Live or let die: The cell's response to p53
  2. Vousden, K. H.; Lu, X.
  3. Nature Reviews Cancer. 2002 2(8): 594-604.
  1. 7.   Hydrocarbon carcinogens evade cellular defense mechanism of G1 arrest in nontransformed and malignant lung cell lines
  2. Khan, Q. A.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2001 173(2): 105-113.
  1. 8.   Activation and activities of the p53 tumour suppressor protein
  2. Balint, E.; Vousden, K. H.
  3. British Journal of Cancer. 2001 85(12): 1813-1823.
  1. 9.   Diverse chemical carcinogens fail to induce G(1) arrest in MCF-7 cells
  2. Khan, Q. A.; Dipple, A.
  3. Carcinogenesis. 2000 21(8): 1611-1618.
  1. 10.   Phosphorylation status and function of p53 are inversely related to protein kinase C activation
  2. Nakamura, K.; Sun, Y.; Yokoyama, Y.; Ferris, D.; Singh, N.; Ichikawa, T.; Shinozuka, K.; Kunitomo, M.; Colburn, N.
  3. Anticancer Research. 2000 20(1A): 1-5.
  1. 11.   Lack of p53-mediated G1 arrest in response to an environmental carcinogen
  2. Khan, Q. A.; Vousden, K. H.; Dipple, A.
  3. Oncology (Huntington). 1999 57(3): 258-264.
  1. 12.   Effect of p53 tumor suppressor on nucleotide excision repair in human colon carcinoma cells treated with 4-nitroquinoline 1-oxide
  2. Seo, Y. R.; Lee, S. H.; Han, S. S.; Ryu, J. C.
  3. Research Communications in Molecular Pathology and Pharmacology. 1999 104(2): 157-+.
  1. 13.   The p16/Cdkn2a/Ink4a gene is frequently deleted in nitrosourea-induced rat glial tumors
  2. Schlegel, J.; Piontek, G.; Kersting, M.; Schuermann, M.; Kappler, R.; Scherthan, H.; Weghorst, C.; Buzard, G.; Mennel, H. D.
  3. Pathobiology. 1999 67(4): 202-206.
  1. 14.   Mechanisms of p53-mediated apoptosis
  2. Bates, S.; Vousden, K. H.
  3. Cellular and Molecular Life Sciences. 1999 55(1): 28-37.
  1. 15.   Characterization of Structural P53 Mutants Which Show Selective Defects in Apoptosis But Not Cell Cycle Arrest
  2. Ryan, K. M.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1998 18(7): 3692-3698.
  1. 16.   Activation of P53 Dna Binding Activity By Point Mutation
  2. Marston, N. J.; Ludwig, R. L.; Vousden, K. H.
  3. Oncogene. 1998 16(24): 3123-3131.
  1. 17.   Cell Cycle Arrest and Dna Endoreduplication Following P21(Waf1/Cip1) Expression
  2. Bates, S.; Ryan, K. M.; Phillips, A. C.; Vousden, K. H.
  3. Oncogene. 1998 17(13): 1691-1703.
  1. 18.   Dispensability of P53 Degradation For Tumorigenicity and Decreased Serum Requirement of Human Papillomavirus Type 16e6
  2. Inoue, T.; Oka, K.; Yongil, H.; Vousden, K. H.; Kyo, S.; Jing, P.; Hakura, A.; Yutsudo, M.
  3. Molecular Carcinogenesis. 1998 21(3): 215-222.
  1. 19.   Genomic Instability and Apoptosis Are Frequent in P53 Deficient Young Mice
  2. Fukasawa, K.; Wiener, F.; Vande Woude, G. F.; Mai
  3. Oncogene. 1997 15(11): 1295-1302.
  1. 20.   Synergy Between the Mos/Mitogen-Activated Protein Kinase Pathway and Loss of P53 Function in Transformation and Chromosome Instability
  2. Fukasawa, K.; Vande Woude, G. F
  3. Molecular and Cellular Biology. 1997 17(1): 506-518.
  1. 21.   Proteolytic Cleavage of Human P53 By Calpain - a Potential Regulator of Protein Stability
  2. Kubbutat, M. H. G.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1997 17(1): 460-468.
  1. 22.   Perturbation of the P53 Response By Human Papillomavirus Type 16 E7
  2. Hickman, E. S.; Bates, S.; Vousden, K. H.
  3. Journal of Virology. 1997 71(5): 3710-3718.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel